1734 found
|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
BELATACEPT |
L04AA28 |
DE
|
I
|
|
None |
01-03-2013 |
VALID
|
|
APREMILAST |
L04AA32 |
DE
|
I
|
|
|
|
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
INFLIXIMAB |
L04AB02 |
DE
|
POM
|
|
|
|
VALID
|
|
ADALIMUMAB |
L04AB04 |
DE
|
POM
|
|
|
|
VALID
|
|
CERTOLIZUMAB PEGOL |
L04AB05 |
DE
|
POM
|
|
|
|
VALID
|
|
GOLIMUMAB |
L04AB06 |
DE
|
POM
|
|
|
|
VALID
|
|
RILONACEPT |
L04AC04 |
DE
|
I
|
|
None |
|
VALID
|
|
SECUKINUMAB |
L04AC10 |
DE
|
POM
|
|
|
|
VALID
|
|
BRODALUMAB |
L04AC12 |
DE
|
POM
|
20-11-2017 |
EMEA/H/C/003959 |
17-07-2017 |
VALID
|
|
SARILUMAB |
L04AC14 |
DE
|
POM
|
20-11-2017 |
EMEA/H/C/004254 |
23-06-2017 |
VALID
|
|
GUSELKUMAB |
L04AC16 |
DE
|
POM
|
04-04-2018 |
EMEA/H/C/004271 |
15-11-2017 |
VALID
|
|
TILDRAKIZUMAB |
L04AC17 |
DE
|
POM
|
12-11-2018 |
EMEA/H/C/004514 |
17-09-2018 |
VALID
|
|
SATRALIZUMAB |
L04AC19 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004788 |
24-06-2021 |
VALID
|
|
BIMEKIZUMAB |
L04AC21 |
DE
|
Not authorised
|
08-10-2021 |
|
|
VALID
|
|
SPESOLIMAB |
L04AC22 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
CICLOSPORIN |
L04AD01 |
DE
|
POM
|
08-04-2019 |
DE/H/4002/005/ |
05-05-2015 |
VALID
|
|
TACROLIMUS |
L04AD02 |
DE
|
POM
|
21-10-2019 |
DE/H/4268/001/P/001 |
11-04-2018 |
VALID
|
|
VOCLOSPORIN |
L04AD03 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
FINGOLIMOD |
L04AE01 |
DE
|
POM
|
07-09-2020 |
|
01-06-2012 |
VALID
|
|
SIPONIMOD |
L04AE03 |
DE
|
POM
|
18-10-2021 |
|
|
VALID
|
|
PONESIMOD |
L04AE04 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005163 |
19-05-2021 |
VALID
|
|
ETRASIMOD |
L04AE05 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
TOFACITINIB |
L04AF01 |
DE
|
POM
|
|
|
|
VALID
|
|
BARICITINIB |
L04AF02 |
DE
|
POM
|
|
|
|
VALID
|
|
UPADACITINIB |
L04AF03 |
DE
|
POM
|
26-04-2022 |
|
|
VALID
|
|
FILGOTINIB |
L04AF04 |
DE
|
POM
|
18-01-2021 |
EMEA/H/C/005113 |
24-09-2020 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
RITLECITINIB |
L04AF08 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
MUROMONAB-CD3 |
L04AG01 |
DE
|
Currently not available
|
|
DE/H/9999/001/II/042 |
06-11-2008 |
VALID
|
|
NATALIZUMAB |
L04AG03 |
DE
|
POM
|
11-10-2017 |
|
|
VALID
|
|
ALEMTUZUMAB |
L04AG06 |
DE
|
POM
|
|
|
|
VALID
|
|
INEBILIZUMAB |
L04AG10 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005818 |
25-04-2022 |
VALID
|
|
ANIFROLUMAB |
L04AG11 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004975 |
14-02-2022 |
VALID
|
|
OFATUMUMAB |
L04AG12 |
DE
|
Not authorised
|
02-06-2021 |
|
|
VALID
|
|
UBLITUXIMAB |
L04AG14 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005914 |
31-05-2023 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
EVEROLIMUS |
L04AH02 |
DE
|
I
|
|
None |
|
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
AVACOPAN |
L04AJ05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005523 |
11-01-2022 |
VALID
|
|
ZILUCOPLAN |
L04AJ06 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005450 |
01-12-2023 |
VALID
|
|
CROVALIMAB |
L04AJ07 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/006061 |
22-08-2024 |
VALID
|
|
IPTACOPAN |
L04AJ08 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005764 |
17-05-2024 |
VALID
|
|
VILOBELIMAB |
L04AJ10 |
DE
|
POM
|
02-05-2025 |
EMEA/H/C/006123 |
13-01-2025 |
VALID
|
|
LEFLUNOMIDE |
L04AK01 |
DE
|
POM
|
14-05-2018 |
DE/H/2310/002/ |
09-08-2012 |
VALID
|
|
TERIFLUNOMIDE |
L04AK02 |
DE
|
POM
|
|
|
|
VALID
|
|
METHOTREXATE |
L04AX03 |
DE
|
POM
|
|
|
|
VALID
|
|
PIRFENIDONE |
L04AX05 |
DE
|
POM
|
05-10-2020 |
|
01-06-2012 |
VALID
|
